Mitsui Chemicals, Inc. (TYO:4183)
Japan · Delayed Price · Currency is JPY 2,191.50
+9.50 (0.44%)
Jul 6, 2026, 3:30 PM JST
Mitsui Chemicals Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,668,754 | 1,809,164 | 1,749,743 | 1,879,547 | 1,612,688 | |
Revenue Growth (YoY) | -7.76% | 3.40% | -6.91% | 16.55% | 33.09% |
Cost of Revenue | 1,288,244 | 1,420,872 | 1,378,946 | 1,498,054 | 1,233,948 |
Gross Profit | 380,510 | 388,292 | 370,797 | 381,493 | 378,740 |
Selling, General & Admin | 294,540 | 295,352 | 220,769 | 225,718 | 188,282 |
Research & Development | - | - | 44,695 | 42,954 | 38,124 |
Other Operating Expenses | 5,809 | 1,978 | -525 | -1,614 | -690 |
Operating Expenses | 300,349 | 297,330 | 284,901 | 290,765 | 245,977 |
Operating Income | 80,161 | 90,962 | 85,896 | 90,728 | 132,763 |
Interest Expense | -8,875 | -8,515 | -7,866 | -6,078 | -4,083 |
Interest & Investment Income | 8,045 | 7,238 | 6,312 | 5,010 | 2,457 |
Earnings From Equity Investments | 17,207 | 12,429 | 12,302 | 21,693 | 25,819 |
Currency Exchange Gain (Loss) | 2,990 | -3,388 | 6,922 | - | - |
Other Non Operating Income (Expenses) | -7,361 | -2,024 | -3,081 | -2,594 | 3,284 |
EBT Excluding Unusual Items | 92,167 | 96,702 | 100,485 | 108,759 | 160,240 |
Impairment of Goodwill | - | - | 939 | - | 7,246 |
Gain (Loss) on Sale of Investments | -21,913 | -18,515 | 2,230 | 23,124 | -4,978 |
Gain (Loss) on Sale of Assets | -8,085 | -9,223 | -6,167 | -7,136 | -5,050 |
Asset Writedown | - | - | -24,156 | -7,455 | -16,183 |
Other Unusual Items | 2,585 | - | - | -14 | -1 |
Pretax Income | 68,608 | 71,647 | 73,331 | 117,278 | 141,274 |
Income Tax Expense | 21,698 | 29,018 | 19,556 | 27,140 | 22,723 |
Earnings From Continuing Operations | 46,910 | 42,629 | 53,775 | 90,138 | 118,551 |
Minority Interest in Earnings | -12,532 | -10,387 | -3,776 | -7,202 | -8,561 |
Net Income | 34,378 | 32,242 | 49,999 | 82,936 | 109,990 |
Net Income to Common | 34,378 | 32,242 | 49,999 | 82,936 | 109,990 |
Net Income Growth | 6.63% | -35.52% | -39.71% | -24.60% | 90.05% |
Shares Outstanding (Basic) | 375 | 378 | 380 | 385 | 389 |
Shares Outstanding (Diluted) | 375 | 378 | 380 | 385 | 389 |
Shares Change (YoY) | -0.76% | -0.57% | -1.16% | -1.11% | 0.16% |
EPS (Basic) | 91.62 | 85.28 | 131.49 | 215.59 | 282.73 |
EPS (Diluted) | 91.62 | 85.28 | 131.49 | 215.59 | 282.73 |
EPS Growth | 7.44% | -35.14% | -39.01% | -23.75% | 89.75% |
Free Cash Flow | 84,746 | 79,288 | 17,271 | -31,106 | -14,483 |
Free Cash Flow Per Share | 225.86 | 209.72 | 45.42 | -80.86 | -37.23 |
Dividend Per Share | 37.500 | 75.000 | 70.000 | 60.000 | 57.500 |
Dividend Growth | -50.00% | 7.14% | 16.67% | 4.35% | 15.00% |
Gross Margin | 22.80% | 21.46% | 21.19% | 20.30% | 23.48% |
Operating Margin | 4.80% | 5.03% | 4.91% | 4.83% | 8.23% |
Profit Margin | 2.06% | 1.78% | 2.86% | 4.41% | 6.82% |
Free Cash Flow Margin | 5.08% | 4.38% | 0.99% | -1.65% | -0.90% |
EBITDA | 171,727 | 179,312 | 181,145 | 182,808 | 216,985 |
EBITDA Margin | 10.29% | 9.91% | 10.35% | 9.73% | 13.46% |
D&A For EBITDA | 91,566 | 88,350 | 95,249 | 92,080 | 84,222 |
EBIT | 80,161 | 90,962 | 85,896 | 90,728 | 132,763 |
EBIT Margin | 4.80% | 5.03% | 4.91% | 4.83% | 8.23% |
Effective Tax Rate | 31.63% | 40.50% | 26.67% | 23.14% | 16.08% |